Masked hypertension and white-coat hypertension: therapeutic navigation between scylla and charybdis.

Blood pressure (BP) is a very labile hemodynamic parameter; it varies from heartbeat to heartbeat, from morning to evening, from winter to summer, from sleeping to awake, and from sitting to standing ([1][1]). The same holds true for any other cardiovascular hemodynamic parameter such as heart rate

[1]  Reversed white-coat hypertension: definition, mechanisms and prognostic implications. , 2002, Journal of hypertension.

[2]  C. Bulpitt,et al.  Response to Antihypertensive Therapy in Older Patients With Sustained and Nonsustained Systolic Hypertension , 2000, Circulation.

[3]  Yutaka Imai,et al.  Prognosis of "masked" hypertension and "white-coat" hypertension detected by 24-h ambulatory blood pressure monitoring 10-year follow-up from the Ohasama study. , 2005, Journal of the American College of Cardiology.

[4]  Peter W de Leeuw,et al.  Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. , 2003, The New England journal of medicine.

[5]  Daniel W. Jones,et al.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. , 2003, Hypertension.

[6]  Kazuomi Kario,et al.  Morning Surge in Blood Pressure as a Predictor of Silent and Clinical Cerebrovascular Disease in Elderly Hypertensives: A Prospective Study , 2003, Circulation.

[7]  J. Staessen,et al.  Properly defining white coat hypertension. , 2002, European heart journal.

[8]  R. Pini,et al.  Cardiac and Arterial Target Organ Damage in Adults with Elevated Ambulatory and Normal Office Blood Pressure , 1999, Annals of Internal Medicine.

[9]  Daniel W. Jones,et al.  Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. , 2005, Hypertension.

[10]  V. Salomaa,et al.  White coat effect, blood pressure and mortality in men: prospective cohort study. , 2000, European heart journal.

[11]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[12]  K. Kario.  Time for focus on morning hypertension: pitfall of current antihypertensive medication. , 2005, American journal of hypertension.

[13]  G. Parati,et al.  Task Force II: Blood pressure measurement and cardiovacular outcome , 2001, Blood pressure monitoring.

[14]  Tine Willum Hansen,et al.  Ambulatory Blood Pressure and Mortality: A Population-Based Study , 2005, Hypertension.

[15]  J. Staessen,et al.  If only cardiologists did properly measure blood pressure. Blood pressure recordings in daily practice and clinical trials. , 2002, Journal of the American College of Cardiology.

[16]  C. Reid,et al.  `Reverse white-coat hypertension’ in older hypertensives , 2002, Journal of hypertension.

[17]  J. Schwartz,et al.  Short- and Long-Term Incidence of Stroke in White-Coat Hypertension , 2005, Hypertension.

[18]  L. Cobb,et al.  Task force II: prehospital and early hospital care. Emergency cardiac care. , 1982, The American journal of cardiology.